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Abstract: Unusual ring contraction 
rearrangement giving spiro-
cyclopropanes from fused-
cyclobutanols have been developed. It 
is found that the strain energy of 
substrates derived from an additional 
fused-ring and the stereoelectronic 
effect of the migrating -bond are 
important factors. It is noteworthy that 
the rearrangement proceeds in a 
stereospecific manner. Moreover, the 
method provides spiro(cyclopropane-
indane) framework from 
tricyclo[6.3.0.02,5]undecane, which 
corresponds to illudane and the 
protoilludane skeleton, respectively. 
Keywords: small rings · ring 
contraction · rearrangements · spiro 




Small ring systems are an important topic in organic chemistry, and 
afford considerable attention from theoretical, synthetic and 
medicinal perspectives. Spirocyclic compounds have also attracted 
to synthetic and medicinal chemists because of their characteristic 
structure. Spiro[n.2]alkanes and alkenes are found in naturally 
occurring substances,[1] such as illudins (Figure 1). Illudin S (1) was 
first discovered as an antibiotic from the Jack O’Lantern mushroom 
Omphalotus olearius. Irofulven (2), which is a hemi-synthetic 
analog derived from illudin S, has been developed as an anticancer 
drug candidate, and is currently in clinical trials for use in solid 
tumor treatments (Phase II).[2] On the basis of the structures of its 
metabolites and structure-activity relationship studies, it has been 
Figure 1. Illudin S and its related compounds 
proposed that the spiro-cyclopropyl structure plays a key function in 
anticancer action.[3] Illudins were postulated to be bio-synthesized 
through 6-protoilludene (3) by a ring contraction rearrangement.[4],[5] 
This biosynthetic mechanism led us to believe that the 
spiro[n.2]alkenes skeleton would be chemically transformed from 
fused-cyclobutanols. 
Due to the inherent ring strains of small ring systems, interesting 
aspects of their reactivity have been well exploited.[6],[7] For example, 
ring expansion rearrangement reactions have been well studied. 
Furthermore, relief of the ring strain is known to produce 
cyclobutane and cyclopentane compounds from cyclopropane and 
cyclobutane derivatives, respectively, by the migration of a C-C 
bond in the ring system.[8] Conversely, the reversal rearrangement 
reaction (ring contraction), which produces a smaller ring system, is 
also possible.[6c],[9] Olah et al have summarized the nature of 
cyclopropylcarbinyl cations, which can be rearranged into 
cyclobutyl cations, and their reactivity.[10] However, studies 
concerning the selective formation of cyclopropyl compounds from 
cyclobutanes are rare for thermodynamic reasons.[11] We believe 
that an increase in strain energy of a cyclobutane substrate through 
the installation of an additional ring would induce the ring 
contraction rearrangement in a cyclopropane compound (Figure 2). 
Thus, planar conformation of sp2 carbocation on the bridgehead of 
fused-cyclobutane C would be thermodynamically unfavourable 
owing to the conformational restriction. PM3 level calculations 
estimate the heat of formation (Hf) of the monocyclic cyclobutyl 
cation A and the corresponding cyclopropylcarbinyl cation B to be 
190.17 and 192.60 kcal/mol, respectively. On the other hand, the 
Hf for cations possessing bicyclo[4.2.0]octane C and 
spiro[4.2]octane D were calculated to be 191.87 and 190.18 
kcal/mol, respectively. In this paper, we describe the unusual ring 
contraction reaction of fused-cyclobutanols producing spirocyclic 
cyclopropanes, spiro[n.2]alkenes, as well as provide mechanistic 
insight. To the best of our knowledge, stereocontrolled methods 
giving spiro[n.2]alkenes bearing substituents on cyclopropane ring, 
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which would be a useful skeleton in medicinal and synthetic 
chemistry, are quite limited.[12] 
Figure 2. PM3 calculated heat of formation of tertiary cyclobutyl cations A,C and 
cylopropylcarbinyl cations B,D. 
Results and Discussion 
Cyclobutanol substrates 4a-j were prepared from silyl enol ethers in 
several steps. A typical synthetic route of 4a, which corresponds to a 
precursor of C (Figure 2), is summarized in Scheme 1. 
Siloxycyclobutane 6 was synthesized from silyl enol ether 5 and 
methyl acrylate by a Tf2NH-catalyzed [2 + 2] cycloaddition, which 
was previously developed by us giving substituted cyclobutanes in a 
concise manner.[13] Reduction of ester moiety of 6, followed by 
desilylation, gave diol 7. Selective protection of the primary 
hydroxyl group of 7 afforded 4 in a good yield. 
Scheme 1. Typical procedure for the preparation of substrate 4a. TBS = tert-
butyldimethylsilyl, DIBAL = diisobutylaluminum hydride, DCM = dichloromethane, 
TBAF = tetra-n-butylammonium fluoride, THF = tetrahydrofuran, Bz = benzoyl, 
DMAP = 4-dimethylaminopyridine 
With a series of cyclobutanols in hand, we examined the ring 
contraction reaction of 4a under conditions for the formation of the 
cyclobutyl cation (Scheme 2). When 4a was treated with several 
acid catalysts, such as conc. H2SO4, TsOH･H2O and BF3･OEt2, a 
complex mixture was obtained but no cyclopropane compound was 
detected. Next, we presumed hat the transformation of the hydroxyl 
group of 4a into a good leaving group would induce the desired 
rearrangement (Table 1). Under the conditions of Sc(III)-catalyzed 
acetylation,[14] the desired cyclopropane 8a was formed in 41% yield 
but the major product was the corresponding acetate (entry 1). 
Treatment of 4a with methanesulfonyl chloride (MsCl; 4.5 equiv.) 
in the presence of excess amounts of 2,6-lutidine gave positive 
results (entries 2-4).  These results indicate that polar solvents are 
preferable for the reaction. Using 2,6-lutidine as a solvent, the ring 
contraction proceeded smoothly, producing 8a in 70% yield (entry 
5). When the reaction was performed using smaller amounts of the 
reagent or at a lower temperature, the chemical yield of 8a was 
reasonable but the reaction required a longer time to complete 
(entries 6 and 7). In all cases, spiro[4.2]octene 8a was obtained as a 
single diastereomer, whose structure as well as stereochemistry were 
determined by 2D-NMR experiments. It should be noted that no 
compound that could  be formed by the rearrangement of another -
bondwere was detected. When thionylchloride (SOCl2) was 
employed as a reagent, 8a was obtained in ca. 55%. Although the 
reaction proceeded rapidly even at room temperature, it produced 
structurally undefined by-products (~10%) which were hard to 
separate from 8a (entry 8). 
Scheme 2. Ring contraction rearrangement of 4a and selected NOE correlations of 8a 
Having established the optimal conditions for the ring 
contraction reaction, we intended to determine its scope and 
limitations with respect to the cyclobutanols bearing varied fused 
rings and substituents (Table 2). Reactions of bicyclo[3.2.0]heptanol 
4b and [5.2.0]nonanol 4c furnished the corresponding 
spirocyclopropanes 8b and 8c, respectively, in good yields (entries 1 
and 2). Differently from the reaction of bicyclo[4.2.0]octanol 4a 
giving endo-olefin 8a, 8b and 8c were obtained as mixtures of endo- 
and exo-olefinic isomers. On the other hand, no rearrangement 
occurred in the reaction of monocyclic cyclobutanol 4d (entry 3). It 
should be mentioned that the rearrangement proceeded in a 
stereospecific manner. Thus, diastereoisomeric 
bicyclo[4.2.0]octanols 4e and 4f gave the spiro[4.2]octenes 8e and 
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Table 1. Optimization of reaction conditions 
entry reagents solvent temp. (oC) time (h)[a] %yield of 8a 
1 Ac2O (5.0 eq), Sc(OTf)3 (4 mol%) MeCN 50 6 41 
2 MsCl (4.5 eq), 2,6-lutidine (6.0 eq) MeCN 50 5 42 
3 MsCl (4.5 eq), 2,6-lutidine (6.0 eq) DCE 80 3 31 
4 MsCl (4.5 eq), 2,6-lutidine (6.0 eq) DMF 50 5 41 
5 MsCl (4.5 eq) 2,6-lutidine 50 2 70 
6 MsCl (2.0 eq) 2,6-lutidine 50 10 65 
7 MsCl (4.5 eq) 2,6-lutidine rt 8 69 
8 SOCl2 (2.5 eq), Et3N (5.0 eq) DCM rt 0.25 ca 55
[b] 
[a] Reaction time was determined when complete consumption of 4a was monitored on TLC. [b] Inseparable byproducts were contained. Ac = acetyl, Tf = 












Table 2. Scope of Ring contraction rearrangement[a] 
[a] Reactions were carried out using 4 (0.10 mmol) and MsCl (4.5 eq) in 2,6-lutidine (1 
M) at 50 oC for 2-20 h, unless otherwise mentioned. [b] at 70 oC. [c] MsCl (4.5 eq), 
NEt3 (6.0 eq) in DCM at 0 
oC to rt. [d] The ratios (endo : exo) were determined by 1H 
NMR. [e] 9k was obtained as a major product in 58% yield. [f] 10l was obtained as a 
by-product in 30% yield. 
5). Compounds 4g and 4h bearing ether and alkyl side chains, 
respectively, on the cyclobutane ring also afforded the 
corresponding spirocyclic compounds in moderate to good yield 
(entries 6 and 7). The result indicates that the contribution of the 
oxygen atom to stabilize the cationic intermediate is not crucial. 
Substrates 4i and 4j, which are installed a keto-carbonyl groups on 
the cyclohexane ring, underwent the rearrangement smoothly to 
furnish spirocyclic enones 8i and 8j, respectively, in high yield 
(entries 8 and 9). On the contrary, in the reaction of 
bicyclo[3.2.0]heptanone 4k, only chloride having enol sulfonate 
moiety 9k was obtained in 50% yield. No desired spiro-
cyclopropane was observed under the conditions tested (entry 10). 
To elucidate the effect of a benzoyloxymethyl substituent on the 
reactivity, the tricyclic substrate 4l bearing no substituent on the 
cyclobutane ring was prepared. Its reaction proceeded to give 
cyclopropane 8l in 50% yield along with chloride 10l in 30% yield 
(entry 11). Formation of 10l indicates that the reaction would 
proceed via the generation of a cyclobutyl cation via mesylate of 4l. 
It is noteworthy that the reaction of 4l into 8l is reasonably 
consistent with the proposed biosynthetic route of illudins from 
protoilludanes.[4] 
The proposed reaction mechanism of the ring contraction 
rearrangement was summarized in Figure 3. After the sulfonylation 
of the tertiary hydroxyl group of 4, the corresponding carbocationic 
intermediate 11 can be generated.[15] Then, the adjacent C-C bond to 
the cation in the cyclobutane ring of 11 can rearrange to give 
spirocyclic cation 12. Finally, irreversible deprotonation would 
result in spiro[n.2]alkene 8. The preferable production of spiro-
cyclopropanes from fused-cyclobutanols can be explained as 
follows: A release of strain energy of the cyclobutyl cation can act 
as a driving force for the rearrangement because the sp2-like 
geometry of the carbocation on cyclobutane ring (11) would be 
unfavourable compared to that on the medium-sized ring (12). In 
this respect, migration of R1-R3 substituents, which also result in the 
formation of the corresponding cyclobutyl cation intermediates, can  
Figure 3. Proposed mechanism for ring contraction rearrangement 
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be ruled out. Moreover, strain energy of a fused-system itself would 
be a trigger to rearrange into spiro-system with migration of C-C 
bond in cyclobutane ring. Clearly, no rearrangement was detected in 
the reaction of the monocyclic system (entry 3 in Table 2). Beyond 
our expectations, the desired rearrangement also proceeds in the 
reaction of 4e, 4f, 4j (R3 = H), although secondary cation 12 would 
be generated as an intermediate from tertiary cation 11 (entries 4,5,9 
in Table 2). Keto carbonyl group in cyclohexane ring (substrates 4i 
and 4j) would accelerate the final elimination step and, therefore, 
resulted in higher yielding of 8. 
Next, we considered stereoelectronic effects on the reactivity in 
order to learn why rearrangement does not occur in the reaction of 
substrate 4k. X-ray crystallographic structures of 4i and 4k and their 
Newman projections viewed along the ring juncture are shown in 
Figure 4.[16] The reaction begins with the generation of the 
carbocation intermediate 11. The structure of should be comparable 
to that of the substrate 4 because a tetrahedral conformation (sp2 
hybridyzed carbon) of the cationic carbon atom at the ring juncture 
position would be more unstable than a sp3-like tetrehedral one. 
Thus, the orientation of the p-orbital of cation 11 would be 
approximated to that of the hydroxyl  bond of 4. It is found that the 
dihedral angle between the hydroxyl substituent and the migrating 
C-C bond of 4i is ca. 137o. Namely, the p-orbital and the C-O 
bonding of intermediate 11 would overlap to some degree and, 
therefore, the rearrangement produces 8i. In contrast, of the angle 
for 4k is almost perpendicular (102o), which would rule out the 
rearrangement.  Suitable crystals for X-ray analysis of the other 
substrates 4 could not be obtained, but X-ray crystallographic 
analysis of cyclobutanols 13b and 13j, which are synthetic 
intermediates of 4b and 4j, respectively, were performed. The 
dihedral angle between C-OH bond and C-C bond for 7b and 13j are 
126o and 143o, respectively (see supporting information). The 
observation would agree with the results that 4b and 4j proceed ring 
contraction reaction.  
Figure 4. X-ray structures and Newman projections of 4i and 4k. Structures of 7b and 
13j. 
Conclusion 
In conclusion, an unusual ring contraction rearrangement giving 
spirocyclic cycropropanes from fused-cyclobutanols is described. It 
is found that the strain energy of substrates derived from an 
additional fused-ring and the stereoelectronic effect of the migrating 
-bond are important factors. It is noteworthy that the 
rearrangement proceeds in a stereospecific manner. Moreover, we 
demonstrated the biomimetic synthesis of 8l from 4l, which 
corresponds to illudane and the protoilludane skeleton, respectively. 
Further studies involving the synthesis of illudines and the 
biological evaluation of synthetic 8 are ongoing in our laboratory. 
Experimental Section 
General: All reactions were carried out under a positive atmosphere of argon in dried 
glassware unless otherwise noted. Solvents and materials were obtained from 
commercial suppliers and used without further purification. Column chromatography 
was performed on Merck silica gel 60 (230-400 mesh). Reactions and chromatography 
fractions were analyzed employing pre-coated silica gel plate (Merck Silica Gel 60 F254). 
All melting points were measured on YANACO MP-500P micro melting point 
apparatus and are uncorrected. IR spectra were measured on JASCO FT/IR-410. The 1H 
and 13C NMR spectra were recorded on JEOL AL-400 or JEOL ECP-500 with 
tetramethylsilane as internal standard. Low-resolution and high-resolution mass spectra 
were recorded on JEOL JMS-01SG-2 or JMS-HX/HX 110A mass spectrometer. X-ray 
crystal analyses were performed on Rigaku RAPID-S. 
General procedure for ring contraction rearrangement of 4: To a solution of 4 (0.10 
mmol) in 2,6-lutidine (0.10 mL) was added MsCl (0.45 mml) at ambient temperature 
under argon atmosphere. After being stirred at 50 oC, the resulting mixture was 
quenched with sat NH4Cl. The aqueous layer was extracted with AcOEt three times. 
The combined organic layers were washed with brine, dried with Na2SO4, and 
concentrated in vacuo. The resulting residue was purified by silica gel chromatography 
(hexane-AcOEt) to give 8. 
(1R*,3R*)-1-Benzoyloxymethyl-4-methylspiro[2.5]oct-4-en (8a): Colorless oil, 1H 
NMR (500 MHz, [D1]chloroform):  = 8.06 (d, J = 7.5 Hz, 2H), 7.55 (t, J = 7.5 Hz, 1H), 
7.44 (dd, J = 7.5, 7.5 Hz, 2H), 5.51 (s, 1H), 4.55 (dd, J = 11.5, 6.9 Hz, 1H), 4.27 (dd, J 
= 11.5, 8.0 Hz, 1H), 2.15-2.05 (m, 2H), 1.75-1.69 (m, 2H), 1.64-1.58 (m, 3H), 1.42 (s, 
3H), 1.10 (dd, J = 8.6, 5.2 Hz, 1H), 0.40 ppm (t, J = 5.2 Hz, 1H); 13C NMR (126 MHz, 
[D1]chloroform):  = 166.7, 135.3, 132.8, 130.5, 129.6, 128.3, 123.4, 65.6, 29.5, 25.9, 
25.3, 22.4, 20.0, 18.2, 16.3 ppm; IR (neat):  2926, 2857, 1719 cm-1; LRMS (FAB): m/z 
257 (M+ + 1); Anal. Calcd. for C17H20O2: C, 79.65; H, 7.86; Found: C, 79.72; H, 8.13. 
(1R*,3R*)-1-Benzoyloxymethyl-4-methylspiro[2.4]hept-4-ene (8b: major isomer): 
colorless oil; 1H NMR (500 MHz, [D1]chloroform):  = 8.06 (dd, J = 8.3, 1.7 Hz, 2H), 
7.56 (t, J = 7.5 Hz, 1H), 7.45 (dd, J = 8.3, 7.5 Hz, 2H), 5.41 (s, 1H), 4.48 (dd, J = 11.7, 
7.1 Hz, 1H), 4.17 (dd, J = 11.7, 8.0 Hz, 1H), 2.44-2.36 (m, 2H), 2.18-2.11 (m, 1H), 
1.96-1.83 (m, 1H), 1.50-1.46 (m, 1H), 1.42 (d, J = 1.9 Hz, 3H), 1.00 (dd, J = 9.0, 5.1 Hz, 
1H), 0.49 ppm (t, J = 5.1 Hz, 1H); 13C NMR (126 MHz, [D1]chloroform):  = 166.7, 
141.2, 132.8, 130.5, 129.6, 128.3, 124.1, 66.8, 35.0, 29.8, 29.0, 17.9, 15.1, 11.5 ppm; IR 
(neat):  2948, 2852, 1718 cm-1; LRMS (FAB): m/z 243 (M+ + 1); Anal. Calcd. for 
C17H20O2: C, 79.65; H, 7.86, found: C, 79.72; H, 8.13. 
(1R*,3R*)-1-Benzoyloxymethyl-4-methylenespiro[2.6]nonane (8c: major isomer): 
colorless oil; 1H NMR (500 MHz, [D1]chloroform):  = 8.07 (d, J = 7.6 Hz, 2H), 7.57 (t, 
J = 7.0 Hz, 1H), 7.44 (dd, J = 7.6, 7.0 Hz, 2H), 5.51 (s, 1H), 4.71 (s, 1H), 4.65 (s, 1H), 
4.57 (dd, J = 11.7, 6.3 Hz, 1H), 4.27 (dd, J = 11.7, 9.3 Hz, 1H), 2.39-2.28 (m, 2H), 
1.80-1.69 (m, 2H), 1.67-1.49 (m, 6H), 1.40-1.36 (m, 1H), 1.05 (dd, J = 9.0, 5.1 Hz, 1H), 
0.51 ppm (t, J = 5.1 Hz, 1H); 13C NMR (126 MHz, [D1]chloroform):  = 166.7, 155.7, 
132.8, 130.4, 129.6, 128.3, 109.1, 65.9, 35.9, 33.3, 29.9, 29.0, 28.9, 27.4, 25.3, 19.7 
ppm; IR (neat):  2925, 2853, 1719 cm-1; LRMS (FAB): m/z 271 (M+ + 1); Anal. Calcd. 
for C18H22O2: C, 79.96; H, 8.20, found: C, 80.15; H, 8.44. 
(1R*,3S*)-1-Benzoyloxymethylspiro[2.5]oct-4-ene (8e): Colorless oil; 1H NMR (500 
MHz, [D1]chloroform):  = 8.06 (d, J = 8.6 Hz, 2H), 7.55 (t, J = 7.3 Hz, 1H), 7.44 (dd, J 
= 8.6, 7.3 Hz, 2H), 5.68 (td, J = 10.0, 3.6 Hz, 1H), 5.00 (td, J = 10.0, 2.0 Hz, 1H), 4.55 
(dd, J = 11.7, 6.6 Hz, 1H), 4.27 (dd, J = 11.7, 8.8 Hz, 1H), 2.09-2.04 (m, 2H), 1.80-1.69 
(m, 3H), 1.65-1.51 (m, 1H), 1.33-1.25 (m, 1H), 0.83 (dd, J = 8.8, 4.9 Hz, 1H), 0.40 ppm 
(t, J = 4.9 Hz, 1H); 13C NMR (126 MHz, [D1]chloroform):  = 166.7, 134.7, 132.8, 
130.5, 129.6, 128.3, 126.2, 65.5, 28.0, 25.1, 23.8, 22.9, 22.2, 19.2 ppm; IR (neat):  
2928, 1718 cm-1; LRMS (FAB) m/z 242 (M+); HRMS (FAB) calcd for C16H18O2 (M
+): 
242.1307, found: 242.1306. 
(1R*,3R*)-1-Benzoyloxymethylspiro[2.5]oct-4-ene (8f): colorless oil ; 1H NMR (500 
MHz, [D1]chloroform):  = 8.05 (d, J = 7.1 Hz, 2H), 7.56 (t, J = 7.3 Hz, 1H), 7.44 (dd, J 
= 7.3, 7.1 Hz, 2H), 5.78 (td, J = 10.0, 3.7 Hz, 1H), 5.32 (td, J = 10.0, 2.2 Hz, 1H), 4.46 
(dd, J = 11.7, 7.1 Hz, 1H), 4.20 (dd, J = 11.7, 8.3 Hz, 1H), 2.10-2.06 (m, 2H), 1.81-1.69 
(m, 2H), 1.65 (dd, J = 9.5, 3.6 Hz, 1H), 1.38-1.32 (m, 1H), 1.29-1.22 (m, 1H), 0.90 (dd, 
























[D1]chloroform):  = 166.7, 132.7, 130.6, 129.6, 129.6, 128.5, 128.3, 66.1, 34.5, 25.6, 
25.3, 23.1, 22.3, 19.9 ppm; IR (neat):  2925, 1714 cm-1; LRMS (FAB) m/z 242 (M+); 
HRMS (FAB) calcd for C16H18O2 (M
+): 242.1307, found: 242.1303. 
(1R*,3R*)-1-Benzyloxymethylspiro[2.5]oct-4-ene (8g): colorless oil ; 1H NMR (500 
MHz, [D1]chloroform):  = 7.35-7.32 (m, 4H), 7.28-7.26 (m, 1H), 5.49 (s, 1H), 4.56 (d, 
J = 12.0, 1H), 4.50 (d, J = 12.0, 1H), 3.54 (dd, J = 10.3, 7.4 Hz, 1H), 2.09-2.02 (m, 2H), 
1.77-1.61 (m, 3H), 1.51-1.42 (m, 2H), 1.40 (s, 3H), 1.02 (dd, J = 9.2, 4.6 Hz, 1H), 0.25 
ppm (t, J = 4.6 Hz, 1H); 13C NMR (126 MHz, [D1]chloroform):  = 138.6, 135.8, 128.3, 
127.7, 127.5, 123.1, 72.7, 70.3, 29.5, 25.9, 24.8, 22.5, 21.0, 18.2, 16.3 ppm; IR (neat):  
2926, 2855 cm-1; LRMS (FAB) m/z 243 (M+ + 1); Anal. Calcd. for C17H22O: C, 84.25; 
H, 9.15, found: C, 84.20; H, 9.25. 
(1R*,3R*)-4-Methyl-1-[(2-phenyl)ethyl]spiro[2.5]oct-4-ene (8h): colorless oil ; 1H 
NMR (500 MHz, [D1]chloroform):  = 7.29-7.25 (m, 2H), 7.20-7.16 (m, 3H), 5.47 (s, 
1H), 2.71 (t, J = 8.0, 1H), 2.09-2.02 (m, 2H), 1.84-1.76 (m, 1H), 1.70-1.54 (m, 4H), 
1.49-1.44 (m, 1H), 1.37 (s, 3H), 1.12-1.05 (m, 1H), 0.93 (dd, J = 9.2, 4.6 Hz, 1H), 0.05 
ppm (t, J = 4.6 Hz, 1H); 13C NMR (126 MHz, [D1]chloroform):  = 142.6, 136.8, 128.4, 
128.2, 125.6, 122.2, 36.4, 31.0, 29.6, 26.0, 24.7, 22.7, 21.6, 18.4, 18.0 ppm; IR (neat):  
2922, 2855 cm-1; LRMS (FAB) m/z 226 (M+); Anal. Calcd. for C17H22: C, 90.20; H, 
9.80, found: C, 90.25; H, 9.71. 
(1R*,3R*)-1-Benzoyloxymethyl-4-methyl-spiro[2.5]oct-4-en-6-one (8i): white solids; 
M.p. 57-58 °C (Hexane/EtOAc); 1H NMR (400 MHz, [D1]chloroform):  = 8.02 (dd, J 
= 8.5, 1.4 Hz, 2H), 7.58 (tt, J = 7.5, 1.4 Hz, 1H), 7.45 (dd, J = 8.5, 7.5 Hz, 2H), 5.97 (s, 
1H), 4.75 (dd, J = 12.0, 6.1 Hz, 1H), 4.21 (dd, J = 12.0, 9.3 Hz, 1H), 2.58-2.43 (m, 2H), 
2.12-1.98 (m, 2H), 1.88-1.80 (m, 1H), 1.70 (d, J = 1.2  Hz, 3H), 1.35 (dd, J = 9.3, 5.4 
Hz, 1H), 0.81 (t, J = 5.4 Hz, 1H) ppm; 13C NMR (126 MHz, [D1]chloroform):  = 199.1, 
166.4, 163.5, 133.2, 129.9, 129.5, 128.5, 127.7, 64.5, 36.8, 28.1, 26.3, 22.5, 19.3, 17.1 
ppm; IR (neat):  2955, 1717, 1665 cm-1; LRMS (FAB) m/z 271 (M+ + 1); HRMS 
(FAB) calcd for C17H19O3 (M
+ + 1): 271.1334, found: 271.1331. 
(1R*,3S*)-1-Benzoyloxymethylspiro[2.5]oct-4-en-6-one (8j): white solids; M.p. 65-
66 °C (Hexane/EtOAc); 1H NMR (400 MHz, [D1]chloroform):  = 8.03 (d, J = 7.1 Hz, 
2H), 7.58 (t, J = 7.4 Hz, 1H), 7.45 (dd, J = 7.4, 7.1 Hz, 2H), 6.23 (d, J = 10.0 Hz, 1H), 
5.99 (d, J = 10.0 Hz, 1H), 4.73 (dd, J = 12.0, 5.8 Hz, 1H), 4.14 (dd, J = 12.0, 9.3 Hz, 
1H), 2.54 (td, J = 7.8, 1.7 Hz, 1H), 2.17-2.10 (m, 1H), 2.06-1.99 (m, 1H), 1.73-1.66 (m, 
1H), 1.18 (dd, J = 9.0, 5.4 Hz, 1H), 0.95 (t, J = 5.4 Hz, 1H) ppm; 13C NMR (126 MHz, 
[D1]chloroform):  = 199.2, 166.4, 157.3, 133.2, 129.9, 128.5, 128.1, 64.4, 36.6, 26.4, 
25.0, 23.9, 19.2 ppm; IR (neat):  2957, 1717, 1672 cm-1; LRMS (FAB) m/z 257 (M+ + 
1); HRMS (FAB) calcd for C16H17O3 (M
+ + 1): 257.1178, found: 257.1182. 
3,3,9-Trimethylbicyclo[4.3.0]nonan-1(5)en-4-one-8-spirocyclopropane (8l): 
colorless oil; 1H NMR (400 MHz, [D1]chloroform):  = 2.49 (dt, J = 18.3, 3.1 Hz, 1H), 
2.30-2.05 (m, 3H), 1.93-1.82 (m, 1H), 1.68 (td, J = 7.6, 7.1 Hz, 1H), 1.12 (s, 3H) , 1.12 
(s, 3H) , 1.11 (s, 3H), 0.96 (ddd, J = 13.5, 5.8, 2.9 Hz, 1H) ppm; 13C NMR (126 MHz, 
[D1]chloroform):  = 203.3, 174.1, 135.4, 45.4, 43.5, 40.8, 27.6, 25.3, 25.3, 21.3, 20.0, 
16.5, 12.8, 9.8 ppm; IR (neat):  2928,1699,1645 cm-1; LRMS (FAB) m/z 204 (M+); 
HRMS (FAB) calcd for C14H20O (M
+): 204.1514, found: 204.1497. 
Crystal data for 4i.: colorless needles (recryst. from hexane-AcOEt), C17H20O4, 
monoclinic, space group P21/n, a = 11.7971(6) Å, b = 7.5796(3) Å, c = 17.7477(8) Å,  
= 104.283(3)°, V= 1537.90(12) Å3, Z = 4, Dcalc = 1.245 g/cm
3, R = 0.0477, Rw = 0.074, 
GOF = 0.854. 
Crystal data for 4k: colorless platelets (recryst. from hexane-AcOEt), C16H18O4, 
triclinic, space group P-1, a = 6.7625(6) Å, b = 9.4963(7) Å, c = 11.2202(9) Å,  = 
101.648(2)°,  = 96.981(3)°,  = 100.873(3)°, V= 683.40(1) Å3, Z = 2, Dcalc = 1.333 
g/cm3, R = 0.0780, Rw = 0.1730, GOF = 1.108. 
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Spiro[n.2]alkenes by Ring 
Contraction of Fused-
Cyclobutanols 
 Rearrangement into cyclopropane 
from cyclobutane: Unusual ring 
contraction rearrangement giving 
spiro-cyclopropanes from fused-
cyclobutanols have been developed. 
It is found that the strain energy of  
substrates derived from an additional 
fused-ring and the stereoelectronic 
effect of the migrating -bond are 
important factors. It is noteworthy 
that the rearrangement proceeds in a 
stereospecific manner. 
 
 
 
